Results 221 to 230 of about 54,330 (287)

Blastoid Variant Mantle Cell Lymphoma with Amplified <i>IGH/CCND1</i> Fusion: A Unique Case and Current Literature Review

Emine Göktaş, Sumeyye Sanal, Hacı Hasan Esen, Atakan Teki̇nalp   +3 more
openalex   +1 more source

Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma. [PDF]

Blood Adv
Darnell EP, Gallagher KME, Kanska J, Scarfò I, Balderrama-Gutierrez G, Berger TR, Budka J, Bozym DJ, Huang T, Shen R, Leick MB, Maus MV.   +11 more
europepmc   +1 more source

Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options? [PDF]

Eur J Haematol
Caserta S, Martino EA, Vigna E, Bruzzese A, Amodio N, Lucia E, Olivito V, Labanca C, Mendicino F, Morabito F, Gentile M.   +10 more
europepmc   +1 more source

گزارش یک مورد لنفوم سلول مانتل با پولیپوز متعدد لنفوماتوز [PDF]

, 2010
روان بد, محمدرضا, طبیب, سیدمسعود, فرزانه, محمدرضا, ولی زاده, سیدمحمد   +3 more
core  

Patient-reported outcomes among patients with mantle cell lymphoma or chronic lymphocytic leukemia receiving pirtobrutinib in the BRUIN phase 1/2 study: final analysis

Catherine C. Coombs, Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Lindsey E. Roeker, Krish Patel, Toby A. Eyre, Constantine S. Tam, John F. Seymour, Nirav N. Shah, Ian W. Flinn, Chan Y. Cheah, Shuo Ma, Joanna Rhodes, Koji Izutsu, Wojciech Jurczak, William G. Wierda, Lisa M. Hess, Naleen Raj Bhandari, Angély Loubert, Paolo B. Abada, Nicole Lamanna   +21 more
openalex   +1 more source

MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma. [PDF]

Blood Adv
Ruan J, Bond DA, Shah B, Allan JN, Rutherford SC, Gribbin C, Chen Z, Bhinder B, Tam W, Rossi D, Xiang J, Hobbie B, Harbhajan M, Sahni TK, Chen GZ, Sigouros M, Inghirami G, Chen-Kiang S, Elemento O, Maddocks K, Leonard JP, Martin P.   +21 more
europepmc   +1 more source

Novel therapeutic agents and intensive chemotherapy improve survival outcomes in patients with mantle cell lymphoma. [PDF]

Am J Cancer Res
Lin ZC, Wang MC, Lin TL, Kuo MC, Kao HW, Chang H, Hung YS, Ma MC, Ong YC, Ou CW, Kuo CY, Chen YY, Huang YM, Shih HJ.   +13 more
europepmc   +1 more source

AIIMS Mantle Cell Lymphoma Overall Survival (AMOS) & AIIMS Mantle Cell Lymphoma Event-Free Survival (AMES) scores: Development of novel indigenous survival prediction models & risk stratification for mantle cell lymphoma in the Indian population. [PDF]

Indian J Med Res
Datta S, Gogia A, Wig N, Pandey S.
europepmc   +1 more source

An Anaplastic Pleomorphic Variant of Mantle Cell Lymphoma. [PDF]

EJHaem
Chiriac R, Donzel M.
europepmc   +1 more source

Bruton Tyrosine Kinase Inhibitors for the Treatment of Relapsed Mantle Cell Lymphoma Involving CNS: Two Case Reports and Literature Review

Евгений Олегович Куневич, Nadezhda N. Nemstsveridze, Mariia Mikhaleva, Alexey Kuvshinov, Т. В. Овчинникова, E. V. Koryakina, Svetlana Samarina, К. Ю. Крутикова, Sergey Sidorkevich, Sergey Voloshin   +9 more
openalex   +2 more sources